EGFR and head and neck squamous cell carcinoma: As discussed in recent studies, by using NMR spectroscopy, HNSCC-specific metabolic features correlated with an acquired EGFR-TKI resistance [42]; the intracellular metabolism therefore becomes one of the potential targets to develop non-canonical anti-HNSCC drugs to better improve therapeutic efficiency.